✦ LIBER ✦

Isomerization and formulation stability of the vaccine adjuvant QS-21

✍ Scribed by Jeffrey L. Cleland; Charlotte R. Kensil; Amy Lim; Neil E. Jacobsen; Louisette Basa; Michael Spellman; Deborah A. Wheeler; Jia-Yan Wu; Michael F. Powell

Book ID: 109388424
Publisher: John Wiley and Sons
Year: 1996
Tongue: English
Weight: 385 KB
Volume: 85
Category: Article
ISSN: 0022-3549
DOI: 10.1021/js9503136

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Synthesis of QS-21-Xylose: Establishment

Synthesis of QS-21-Xylose: Establishment of the Immunopotentiating Activity of Synthetic QS-21 Adjuvant with a Melanoma Vaccine

✍ Kai Deng; Michelle M. Adams; Payal Damani; Philip O. Livingston; Govind Ragupath 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 401 KB 👁 1 views

Synthesis of QS-21-Xylose: Establishment

Synthesis of QS-21-Xylose: Establishment of the Immunopotentiating Activity of Synthetic QS-21 Adjuvant with a Melanoma Vaccine

✍ Kai Deng; Michelle M. Adams; Payal Damani; Philip O. Livingston; Govind Ragupath 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 401 KB 👁 1 views

The potential malaria vaccine `Quilimmun

The potential malaria vaccine `Quilimmune-M', containing the synthetic peptide antigen SPf66 and the adjuvant QS-21*,

📂 Article 📅 1998 🏛 Adis International Limited (now part of Wolters Kl ⚖ 109 KB

Safety, tolerability and immunogenicity

Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21

✍ Oscar Kashala; Roberto Amador; Maria V. Valero; Alberto Moreno; Arnoldo Barbosa; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 206 KB

Stabilization of alum-adjuvanted vaccine

Stabilization of alum-adjuvanted vaccine dry powder formulations: Mechanism and application

✍ Yuh-Fun Maa; Lu Zhao; Lendon G. Payne; Dexiang Chen 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 519 KB

Studies were performed to elucidate the mechanism of alum gel coagulation upon freezing and drying and its relationship to vaccine potency loss and to develop a novel freeze-drying process for the production of stable alum-adjuvanted vaccine formulations suitable for conventional needle injection an

Formulation, stability and immunogenicit

Formulation, stability and immunogenicity of a trivalent pneumococcal protein vaccine formulated with aluminum salt adjuvants

✍ Belma Ljutic; Martina Ochs; Benjamin Messham; Marin Ming; Annie Dookie; Kevin Ha 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 530 KB